Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Goes LR"'
Autor:
Girard A; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Vimonpatranon S; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA; Department of Retrovirology, Walter Reed Army Institute of Research-Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand., Chan A; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Jiang A; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Huang DW; NCI, Lymphoid Malignancy Branch, Bethesda, Maryland, USA., Virtaneva K; National Institute of Allergy and Infectious Diseases, Research Technologies Section, Genomics Unit, Rocky Mountain Laboratory, Hamilton, Montana, USA., Kanakabandi K; National Institute of Allergy and Infectious Diseases, Research Technologies Section, Genomics Unit, Rocky Mountain Laboratory, Hamilton, Montana, USA., Martens C; National Institute of Allergy and Infectious Diseases, Research Technologies Section, Genomics Unit, Rocky Mountain Laboratory, Hamilton, Montana, USA., Goes LR; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA; INCA, Rio de Janeiro, Brazil., Soares MA; INCA, Rio de Janeiro, Brazil., Licavoli I; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., McMurry J; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Doan P; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Wertz S; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Wei D; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Ryk DV; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Ganesan S; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Hwang IY; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Kehrl JH; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Martinelli E; Northwestern Feinberg School of Medicine, Division of Infectious Diseases, Chicago, Illinois, USA., Arthos J; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA., Cicala C; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, Bethesda, Maryland, USA. Electronic address: ccicala@niaid.nih.gov.
Publikováno v:
Mucosal immunology [Mucosal Immunol] 2024 Aug; Vol. 17 (4), pp. 700-712. Date of Electronic Publication: 2024 May 08.
Autor:
Van Ryk D; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Vimonpatranon S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.; Department of Retrovirology, Armed Forces Research Institute of Medical Sciences-United States Component, Bangkok, Thailand., Hiatt J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Ganesan S; Biological Imaging Section, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Chen N; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., McMurry J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Garba S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Min S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Goes LR; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.; Oncovirology Program, Instituto Nacional de Câncer, Rio de Janeiro, Rio de Janeiro, Brazil., Girard A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Yolitz J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Licavoli I; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Wei D; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Huang D; Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Soares MA; Oncovirology Program, Instituto Nacional de Câncer, Rio de Janeiro, Rio de Janeiro, Brazil.; Department of Genetics, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Martinelli E; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America., Cicala C; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Arthos J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2023 Dec 08; Vol. 19 (12), pp. e1011860. Date of Electronic Publication: 2023 Dec 08 (Print Publication: 2023).
Autor:
Britto AMA; Departamento de Enfermagem Materno-Infantil (DEMI), Faculdade de Enfermagem (FEnf), Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.; Programa de Oncovirologia, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.; Programa de Pós-Graduação em Infecção HIV/aids e Hepatites Virais, Hospital Universitário Gaffrée e Guinle (HUGG/Ebserh), Universidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil., Siqueira JD; Programa de Oncovirologia, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Curty G; Programa de Oncovirologia, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Goes LR; Programa de Oncovirologia, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Policarpo C; Laboratório de Genômica Funcional e Transdução de Sinal, Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil., Meyrelles AR; Instituto de Ginecologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Furtado Y; Instituto de Ginecologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Escola de Medicina e Cirurgia da Universidade Federal do Estado do Rio de Janeiro, Universidade Federal do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil., Almeida G; Instituto de Ginecologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Giannini ALM; Laboratório de Genômica Funcional e Transdução de Sinal, Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil., Machado ES; Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Soares MA; Programa de Oncovirologia, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Apr 25; Vol. 14, pp. 1147950. Date of Electronic Publication: 2023 Apr 25 (Print Publication: 2023).
Autor:
Vimonpatranon S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.; Graduate Program in Immunology, Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Center of Excellence for Microparticle and Exosome in Diseases, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Goes LR; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.; Oncovirology Program, Instituto Nacional de Câncer, Rio de Janeiro, Brazil., Chan A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Licavoli I; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., McMurry J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Wertz SR; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Arakelyan A; Eunice Kennedy-Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, United States of America.; Georgiamune, Gaithersburg, Maryland, United States of America., Huang D; Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Jiang A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Huang C; Bioinformatics Program, St. Bonaventure University, St. Bonaventure, New York, United States of America., Zhou J; Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, United States of America., Yolitz J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Girard A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Van Ryk D; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Wei D; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Hwang IY; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Martens C; Research Technologies Section, Genomics Unit, Rocky Mountain Laboratory, National Institutes of Allergy and Infectious Diseases, Hamilton, Montana, United States of America., Kanakabandi K; Research Technologies Section, Genomics Unit, Rocky Mountain Laboratory, National Institutes of Allergy and Infectious Diseases, Hamilton, Montana, United States of America., Virtaneva K; Research Technologies Section, Genomics Unit, Rocky Mountain Laboratory, National Institutes of Allergy and Infectious Diseases, Hamilton, Montana, United States of America., Ricklefs S; Research Technologies Section, Genomics Unit, Rocky Mountain Laboratory, National Institutes of Allergy and Infectious Diseases, Hamilton, Montana, United States of America., Darwitz BP; Research Technologies Section, Genomics Unit, Rocky Mountain Laboratory, National Institutes of Allergy and Infectious Diseases, Hamilton, Montana, United States of America., Soares MA; Oncovirology Program, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.; Department of Genetics, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Pattanapanyasat K; Graduate Program in Immunology, Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Center of Excellence for Microparticle and Exosome in Diseases, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Fauci AS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Arthos J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Cicala C; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2023 Mar 10; Vol. 19 (3), pp. e1011209. Date of Electronic Publication: 2023 Mar 10 (Print Publication: 2023).
Autor:
Goes LR; Oncovirology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States., Siqueira JD; Oncovirology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Garrido MM; Hospital Infection Control Committee, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Alves BM; Oncovirology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Cicala C; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States., Arthos J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States., Viola JPB; Immunology and Tumor Biology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Soares MA; Oncovirology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Publikováno v:
Frontiers in microbiology [Front Microbiol] 2022 Jul 26; Vol. 13, pp. 946549. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).
Autor:
Goes LR; Oncovirology Program, Brazilian National Cancer Institute, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Building 10 Room 6A08, 9000 Rockville Pike, Bethesda, MD 20892, USA. Electronic address: livia.goes@inca.gov.br., Siqueira JD; Oncovirology Program, Brazilian National Cancer Institute, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil. Electronic address: juliana.siqueira@inca.gov.br., Garrido MM; Hospital Infection Control Committee, Brazilian National Cancer Institute, Praça Cruz Vermelha, 23, Rio de Janeiro, RJ 20230-130, Brazil. Electronic address: Marianne.Monteiro@inca.gov.br., Alves BM; Oncovirology Program, Brazilian National Cancer Institute, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil. Electronic address: brunnamisael@gmail.com., Pereira ACPM; Section of Anesthesiology, Brazilian National Cancer Institute, Praça Cruz Vermelha, 23, Rio de Janeiro, RJ 20230-130, Brazil. Electronic address: ana.pinho@inca.gov.br., Cicala C; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Building 10 Room 6A08, 9000 Rockville Pike, Bethesda, MD 20892, USA. Electronic address: ccicala@niaid.nih.gov., Arthos J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Building 10 Room 6A08, 9000 Rockville Pike, Bethesda, MD 20892, USA. Electronic address: jarthos@niaid.nih.gov., Viola JPB; Program of Immunology and Tumor Biology, Brazilian National Cancer Institute, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil. Electronic address: jpviola@inca.gov.br., Soares MA; Oncovirology Program, Brazilian National Cancer Institute, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil; Department of Genetics, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, 373, Rio de Janeiro, RJ 21941-590, Brazil. Electronic address: masoares@inca.gov.br.
Publikováno v:
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Infect Genet Evol] 2021 Oct; Vol. 94, pp. 104998. Date of Electronic Publication: 2021 Jul 10.
Autor:
Siqueira JD; Programa de Oncovirologia, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil., Goes LR; Programa de Oncovirologia, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10 Room 6A08, 9000 Rockville Pike, Bethesda, MD 20892, USA., Alves BM; Programa de Oncovirologia, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil., da Silva ACP; Hospital do Câncer II, Instituto Nacional de Câncer, Avenida Via Binário do Porto, 831, Rio de Janeiro, RJ 20081-250, Brazil., de Carvalho PS; Programa de Oncovirologia, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil., Cicala C; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10 Room 6A08, 9000 Rockville Pike, Bethesda, MD 20892, USA., Arthos J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10 Room 6A08, 9000 Rockville Pike, Bethesda, MD 20892, USA., Viola JPB; Programa de Imunologia e Biologia de Tumores, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil., Soares MA; Programa de Oncovirologia, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil; Departamento de Genética, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373, Rio de Janeiro, RJ 21941-402, Brazil. Electronic address: masoares@inca.gov.br.
Publikováno v:
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Infect Genet Evol] 2021 Jun; Vol. 90, pp. 104772. Date of Electronic Publication: 2021 Feb 14.
Autor:
Siqueira JD; Programa de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20.231-050, Brazil., Goes LR; Programa de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20.231-050, Brazil.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA., Alves BM; Programa de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20.231-050, Brazil., de Carvalho PS; Programa de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20.231-050, Brazil., Cicala C; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA., Arthos J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA., Viola JPB; Programa de Imunologia e Biologia de Tumores, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20.231-050, Brazil., de Melo AC; Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20.231-050, Brazil., Soares MA; Programa de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20.231-050, Brazil.
Publikováno v:
Virus evolution [Virus Evol] 2021 Feb 16; Vol. 7 (1), pp. veab013. Date of Electronic Publication: 2021 Feb 16 (Print Publication: 2021).
Autor:
Goes LR; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814; livia.goes@nih.gov afauci@nih.gov.; Instituto Nacional de Câncer, Rio de Janeiro, 20231-050, Brazil., Sajani A; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814., Sivro A; Centre for the AIDS Programme of Research in South Africa (CAPRISA), 4013 Durban, South Africa., Olowojesiku R; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814., Ray JC; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814., Perrone I; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814., Yolitz J; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814., Girard A; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814., Leyre L; Icahn School of Medicine at Mount Sinai, New York, NY 10029., Wibmer CK; National Institute for Communicable Diseases of the National Health Laboratory Service, 2192 Johannesburg, South Africa., Morris L; National Institute for Communicable Diseases of the National Health Laboratory Service, 2192 Johannesburg, South Africa., Gorini G; Animal Models and Vaccine Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814., Franchini G; Animal Models and Vaccine Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814., Mason RD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20814., Roederer M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20814., Mehandru S; Icahn School of Medicine at Mount Sinai, New York, NY 10029., Soares MA; Instituto Nacional de Câncer, Rio de Janeiro, 20231-050, Brazil.; Universidade Federal do Rio de Janeiro, Rio de Janeiro, 21941-902, Brazil., Cicala C; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814., Fauci AS; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814; livia.goes@nih.gov afauci@nih.gov., Arthos J; Laboratory of Immunoregulation, National Institutes of Health, Bethesda, MD 20814.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Dec 22; Vol. 117 (51), pp. 32566-32573. Date of Electronic Publication: 2020 Dec 07.
Autor:
Britto AMA; Programa de Oncovirologia, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.; Laboratório de Genômica Funcional e Transdução de Sinal, Departamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Goes LR; Programa de Oncovirologia, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Sivro A; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada.; Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa., Policarpo C; Laboratório de Genômica Funcional e Transdução de Sinal, Departamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Meirelles ÂR; Instituto de Ginecologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Furtado Y; Instituto de Ginecologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Almeida G; Instituto de Ginecologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Arthos J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Cicala C; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Soares MA; Programa de Oncovirologia, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Machado ES; Laboratório de Genômica Funcional e Transdução de Sinal, Departamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Giannini ALM; Laboratório de Genômica Funcional e Transdução de Sinal, Departamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Sep 03; Vol. 11, pp. 2078. Date of Electronic Publication: 2020 Sep 03 (Print Publication: 2020).